Mark A. Weinberg
Plus aucun poste en cours
Profil
Mark A.
Weinberg worked as the Chief Medical Officer & Managing Director at Halloran Consulting Group, Inc. He was also the Vice President-Global Clinical Science at Astellas Pharma Global Development, Inc. from 2011 to 2014 and the Senior Vice President-Clinical Development at RestorGenex Corp.
from 2014 to 2016.
He held the position of Senior Vice President-Clinical Development at Diffusion Pharmaceuticals, Inc. Dr. Weinberg completed his undergraduate degree at Yale University, earned an MBA from Kellogg School of Management, and obtained a doctorate from Duke University School of Medicine.
Anciens postes connus de Mark A. Weinberg
| Sociétés | Poste | Fin |
|---|---|---|
RestorGenex Corp.
 RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Corporate Officer/Principal | 08/01/2016 |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Directeur Technique/Scientifique/R&D | 01/05/2014 |
| DIFFUSION PHARMA | Corporate Officer/Principal | - |
Halloran Consulting Group, Inc.
 Halloran Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Halloran Consulting Group, Inc. provides management consulting services for the life science industry. Its services include clinical development, due diligence, organizational development, program management, gap analysis, clinical finance, change management, vendor management, inspection readiness, training and technology adoption. The company was founded by Laurie Halloran in 1998 and is headquartered in Boston, MA. | Directeur Technique/Scientifique/R&D | - |
Formation de Mark A. Weinberg
| Yale University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Health Technology |
Halloran Consulting Group, Inc.
Halloran Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Halloran Consulting Group, Inc. provides management consulting services for the life science industry. Its services include clinical development, due diligence, organizational development, program management, gap analysis, clinical finance, change management, vendor management, inspection readiness, training and technology adoption. The company was founded by Laurie Halloran in 1998 and is headquartered in Boston, MA. | Commercial Services |
Diffusion Pharmaceuticals, Inc.
 Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Diffusion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing novel therapies that enhance the body's ability to deliver oxygen. The firm's product candidate, Trans Sodium Crocetinate, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. | Health Technology |
